Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Go back to Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
(NASDAQ: MIRM) Delayed: 99.53 -1.37 (1.36%)
Previous Close $100.90    52 Week High
Open $98.49    52 Week Low
Day High $101.83    P/E N/A 
Day Low $97.65    EPS
Volume 638,466